FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904391246> ?p ?o ?g. }

• W2904391246 endingPage "600" @default.
• W2904391246 startingPage "590" @default.
• W2904391246 abstract "Aim The aim of this study was to characterize the effect of inotuzumab ozogamicin on QT interval in patients with B‐cell malignancies. Methods Data were pooled from three clinical studies including 250 patients ( n = 2743) who received inotuzumab ozogamicin monotherapy. Patients with relapsed/refractory acute lymphoblastic leukaemia (NCT01564784 and NCT01363297) received 1.8 mg m −2 per cycle in divided doses (mean C max 371 ng ml −1 ; considered therapeutic) and patients with relapsed/refractory non‐Hodgkin lymphoma (NCT00868608) received 1.8 mg m −2 per cycle as a single dose (mean C max 569 ng ml −1 ; considered supratherapeutic). Triplicate 12‐lead electrocardiograms were performed at baseline and predefined time points postdose with paired pharmacokinetic collections. The exposure–response relationship between corrected QT interval (QTc: QT interval corrected using population‐specific formula [QTcS] or QT interval corrected using Fridericia's formula [QTcF]) and inotuzumab ozogamicin concentration was characterized using a linear mixed‐effects model, and simulations were performed using the final validated model. Full model development involved testing for covariates that may account for part of the identified variability. Results QTc intervals had a small but positive correlation with inotuzumab ozogamicin concentration. Based on 1000 simulations, median (upper 95% CI) QTcS and QTcF changes from baseline were <10 ms at both therapeutic (2.70 ms [5.40 ms] and 2.53 ms [4.92 ms], respectively) and supratherapeutic (4.14 ms [8.28 ms] and 3.87 ms [7.54 ms], respectively) concentrations. Conclusions Inotuzumab ozogamicin (1.8 mg m −2 per cycle) is not predicted to pose a clinically significant safety risk for QT prolongation in patients with acute lymphoblastic leukaemia or non‐Hodgkin lymphoma." @default.
• W2904391246 created "2018-12-22" @default.
• W2904391246 creator A5017509777 @default.
• W2904391246 creator A5069542012 @default.
• W2904391246 creator A5082924494 @default.
• W2904391246 creator A5090435894 @default.
• W2904391246 date "2019-01-21" @default.
• W2904391246 modified "2023-10-01" @default.
• W2904391246 title "Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc‐concentration modelling" @default.
• W2904391246 cites W1943300686 @default.
• W2904391246 cites W2002862326 @default.
• W2904391246 cites W2012149136 @default.
• W2904391246 cites W2042553471 @default.
• W2904391246 cites W2056994982 @default.
• W2904391246 cites W2057680307 @default.
• W2904391246 cites W2058509406 @default.
• W2904391246 cites W2066508515 @default.
• W2904391246 cites W2082426693 @default.
• W2904391246 cites W2100128674 @default.
• W2904391246 cites W2126855868 @default.
• W2904391246 cites W2131308754 @default.
• W2904391246 cites W2150648608 @default.
• W2904391246 cites W2166723281 @default.
• W2904391246 cites W2337841974 @default.
• W2904391246 cites W2346128427 @default.
• W2904391246 cites W2419639370 @default.
• W2904391246 cites W2604901999 @default.
• W2904391246 cites W2725721905 @default.
• W2904391246 cites W2767041448 @default.
• W2904391246 cites W2771291368 @default.
• W2904391246 cites W2771328536 @default.
• W2904391246 cites W2951813451 @default.
• W2904391246 cites W4256002130 @default.
• W2904391246 doi "https://doi.org/10.1111/bcp.13832" @default.
• W2904391246 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6379221" @default.
• W2904391246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30536405" @default.
• W2904391246 hasPublicationYear "2019" @default.
• W2904391246 type Work @default.
• W2904391246 sameAs 2904391246 @default.
• W2904391246 citedByCount "9" @default.
• W2904391246 countsByYear W29043912462019 @default.
• W2904391246 countsByYear W29043912462020 @default.
• W2904391246 countsByYear W29043912462021 @default.
• W2904391246 countsByYear W29043912462022 @default.
• W2904391246 countsByYear W29043912462023 @default.
• W2904391246 crossrefType "journal-article" @default.
• W2904391246 hasAuthorship W2904391246A5017509777 @default.
• W2904391246 hasAuthorship W2904391246A5069542012 @default.
• W2904391246 hasAuthorship W2904391246A5082924494 @default.
• W2904391246 hasAuthorship W2904391246A5090435894 @default.
• W2904391246 hasBestOaLocation W29043912461 @default.
• W2904391246 hasConcept C112705442 @default.
• W2904391246 hasConcept C118441451 @default.
• W2904391246 hasConcept C121332964 @default.
• W2904391246 hasConcept C126322002 @default.
• W2904391246 hasConcept C142424586 @default.
• W2904391246 hasConcept C164705383 @default.
• W2904391246 hasConcept C42219234 @default.
• W2904391246 hasConcept C44249647 @default.
• W2904391246 hasConcept C71924100 @default.
• W2904391246 hasConcept C87355193 @default.
• W2904391246 hasConceptScore W2904391246C112705442 @default.
• W2904391246 hasConceptScore W2904391246C118441451 @default.
• W2904391246 hasConceptScore W2904391246C121332964 @default.
• W2904391246 hasConceptScore W2904391246C126322002 @default.
• W2904391246 hasConceptScore W2904391246C142424586 @default.
• W2904391246 hasConceptScore W2904391246C164705383 @default.
• W2904391246 hasConceptScore W2904391246C42219234 @default.
• W2904391246 hasConceptScore W2904391246C44249647 @default.
• W2904391246 hasConceptScore W2904391246C71924100 @default.
• W2904391246 hasConceptScore W2904391246C87355193 @default.
• W2904391246 hasIssue "3" @default.
• W2904391246 hasLocation W29043912461 @default.
• W2904391246 hasLocation W29043912462 @default.
• W2904391246 hasLocation W29043912463 @default.
• W2904391246 hasOpenAccess W2904391246 @default.
• W2904391246 hasPrimaryLocation W29043912461 @default.
• W2904391246 hasRelatedWork W2068316626 @default.
• W2904391246 hasRelatedWork W2110818089 @default.
• W2904391246 hasRelatedWork W2351796763 @default.
• W2904391246 hasRelatedWork W2351985199 @default.
• W2904391246 hasRelatedWork W2371249220 @default.
• W2904391246 hasRelatedWork W2403502999 @default.
• W2904391246 hasRelatedWork W2531678307 @default.
• W2904391246 hasRelatedWork W2567738959 @default.
• W2904391246 hasRelatedWork W4297834875 @default.
• W2904391246 hasRelatedWork W4366141624 @default.
• W2904391246 hasVolume "85" @default.
• W2904391246 isParatext "false" @default.
• W2904391246 isRetracted "false" @default.
• W2904391246 magId "2904391246" @default.
• W2904391246 workType "article" @default.